کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
6113623 1212338 2015 12 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Economic burden of chemotherapy-induced febrile neutropenia in patients with lymphoma: A systematic review
ترجمه فارسی عنوان
بار اقتصادی از نوتروپنی تب ناشی از شیمیدرمانی در بیماران مبتلا به لنفوم: بررسی سیستماتیک
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی هماتولوژی
چکیده انگلیسی
The primary objective of this review was to identify the cost components that were most frequently associated with the economic burden of febrile neutropenia (FN) among patients with lymphoma. The secondary objective was to identify any parameter associated with higher FN cost. Ten cost of illness (COI) studies were identified. General characteristics on study design, country, perspective, and patient population were extracted and systematically reported. It was observed that majority (70%) of the studies employed the perspective of healthcare provider. 20% of the studies considered long-term costs. Estimated costs were adjusted to 2013 US dollars and ranged from US$5819 to US$34,756. The cost components that were most frequently associated with economic burden were ward and medication costs. Inpatient management, male gender, discharged dead, and comorbidity were positively associated with higher FN costs. Future COI studies on FN should focus on the accurate estimation on ward and medication costs.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Critical Reviews in Oncology/Hematology - Volume 94, Issue 2, May 2015, Pages 201-212
نویسندگان
, , ,